This is very inaccurate. If you want to do some real DD Kunt, go back and compare the results from the CelSCi trial to the historical control arm that is being used for the DC-Vax trial. And you'll notice that DC-Vax passes with flying colors and CelSci's treatment fails significantly.
One is GBM and the other is Head and Neck. Can not compare them.
But if you wish to, CVM reported against a 5 year OS in the MI w/o chemo population. Even is the MI + chemo partients drop it, will still be 40%+ or so.
DCVax-L has no chance of hitting those 5y US numbers.
I will repeat that the comparison is absurd. But you are one calling it real DD. So at least get your real DD correct.
Market Data 
Markets 
AI
